Bone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationGraft vs Host DiseaseWhole-Body IrradiationBone MarrowTransplantation, AutologousStem Cell TransplantationBusulfanAnemia, AplasticBone Marrow CellsLeukemiaTransplantation ConditioningHistocompatibility TestingLiver TransplantationGraft vs Host ReactionTransplantation ChimeraCyclophosphamideGraft SurvivalTissue DonorsRecurrenceStem CellsHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationHistocompatibilityKidney TransplantationHematopoietic Stem CellsMethotrexateCytomegalovirus InfectionsTreatment OutcomeGraft RejectionImmunosuppressive AgentsCombined Modality TherapyTransplantation, IsogeneicBone Marrow PurgingRemission InductionHeart TransplantationFollow-Up StudiesLeukemia, Myeloid, AcuteImmunosuppressionHematopoiesisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation ImmunologyTime FactorsLymphocyte DepletionRetrospective StudiesBone and BonesSurvival AnalysisCord Blood Stem Cell TransplantationLung TransplantationCell TransplantationHepatic Veno-Occlusive DiseaseHLA AntigensAcute DiseaseMice, Inbred C57BLPrecursor Cell Lymphoblastic Leukemia-LymphomaT-LymphocytesMesenchymal Stem Cell TransplantationCyclosporineGraft vs Leukemia EffectBone Marrow DiseasesOrgan TransplantationRadiation ChimeraLymphoma, Non-HodgkinMultiple MyelomaMelphalanMyelodysplastic SyndromesGraft vs Tumor EffectSurvival RateNuclear FamilyLeukemia, MyeloidHematologic DiseasesCell DifferentiationAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsLymphocyte TransfusionDisease-Free SurvivalLeukocyte TransfusionSevere Combined ImmunodeficiencyIslets of Langerhans TransplantationHematopoietic Stem Cell MobilizationInfectionAntigens, CD34TransplantationGranulocyte Colony-Stimulating FactorBone Marrow ExaminationChimerismCytarabineChimeraPancreas TransplantationAntilymphocyte SerumColony-Forming Units AssayCarmustineSalvage TherapyActuarial AnalysisFlow CytometryCells, CulturedEtoposideLiving DonorsTransplantation Tolerance